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Abstract
Background. Microalbuminuria (MA) has been shown
to be an early biomarker of renal damage. It is postulated
that MA is the early result of hyperﬁltration, which could
evolve into glomerular sclerosis and renal failure if hyper-
ﬁltration is left untreated. We hypothesized that MA is a
good indicator of hyperﬁltration in children with kidney
disorders, obviating the need to calculate the ﬁltration
fraction (FF).
Methods. A total of 155 children or young adults were
prospectively included [42 single kidney (SK), 61 vesico-
ureteral reﬂux, 23 obstructive uropathies, 29 other kidney
diseases]. We measured inulin, para-aminohippuric acid
clearances, FF and MA. Prediction of hyperﬁltration was
explored by studying the association between the FF and
other variables such as urinary albumin (Alb), urinary
albumin–creatinine ratio (ACR) and creatinine clearance.
Results. A signiﬁcant but weak association between urinary
Alb or ACR and FF was found in subjects with an SK
(Spearman correlation coefﬁcients 0.32 and 0.19, respect-
ively). Multivariate analysis also showed that urinary Alb
and ACR signiﬁcantly predict FF only in subjects with an
SK (r2 = 0.17, P = 0.01 and r2 = 0.13, P = 0.02, respectively).
This holds true only in subjects with an SK and inulin clear-
ance >90 mL/min/1.73 m2 (r2 = 0.41, P < 0.001). There was
no association between creatinine clearance and FF.
Conclusions. MA is not associated with FF in our subjects
with nephro-urological disorders, except in those with an SK,
where the association is weak, indicating that MA is due to
other mechanisms than high FF and cannot predict hyperﬁl-
tration in such groups.
Keywords: hyperﬁltration; microalbuminuria; single kidney; urinary
biomarker
Introduction
In recent years, there has been a dramatic increase in the
prevalence of chronic kidney disease (CKD) in the adult
population, mainly due to an epidemic of hypertension
and diabetes mellitus (DM). It is estimated that as much
as 35% of people aged 64 years and older present a low
glomerular ﬁltration rate (GFR). Although such an in-
crease in the prevalence of CKD has not been observed in
children, there are several recently recognized conditions
that put them at risk of developing CKD later in life, such
as low birth weight, obesity and hypertension [1].
The pathophysiology leading to CKD is complex. One
of the best recognized mechanisms is hyperﬁltration: a de-
creased nephron number [low birth weight, nephrectomy,
single kidney (SK), recurrent pyelonephritis, chronic glo-
merulonephritis] produces a state of hyperﬁltration in the
remaining nephrons, which is then thought to induce
focal and segmental glomerulosclerosis (FSGS), further
damaging the remaining nephrons and fuelling this
vicious cycle [2, 3].
The evaluation of hyperﬁltration is often unavailable in
most paediatric clinics. In order to do so, one needs to
concomitantly measure inulin and p-aminohippuric acid
(PAH) clearances, which is time consuming and invasive
since it involves catheter-collected urine in young chil-
dren. A good marker that would predict hyperﬁltration
and obviate the need for inulin and PAH clearances
would be most desirable. Microalbuminuria (MA) has
been proposed as an early marker of glomerular hyperﬁl-
tration, especially in patients with obesity, hypertension or
DM [4–6].
Studies speciﬁcally looking at glomerular hyperﬁltra-
tion and MA in the paediatric population are scarce, and
show conﬂicting results. Schreuder et al. found that chil-
dren with an SK often present MA; however, in their
study, clearances and FF were not assessed [7]. In another
study, Basic et al. looked at the presence of MA in chil-
dren with vesico-ureteral reﬂux (VUR) [8], again with no
evaluation of the FF. It is therefore impossible to know
whether MA in the reported children is then secondary to
a high FF or to chronic renal parenchymal damage such
as interstitial ﬁbrosis, inﬂammation and scars.
The association between FF and MA in subjects with
DM has been studied by several authors, and conclusions
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are controversial. Ficociello et al. found that in adult
patients with long-lasting DM, renal hyperﬁltration did
not have an impact on the development of MA during 5,
10 or 15 years of follow-up [9]. Yip et al. also found no
association between hyperﬁltration and MA in a 10-year
prospective case–control study of adults with Type 1 DM
[10]. On the other hand, several authors found a signiﬁ-
cant association between hyperﬁltration and MA in chil-
dren with DM [11, 12]. This has been conﬁrmed in a
recent meta-analysis [13].
Our study aimed to examine the relationship between
MA and FF in subjects with common nephro-urological
disorders. We hypothesized that the presence of MA in
these patients would indicate a state of hyperﬁltration. If
correct, the hypothesis would be particularly useful in
subjects with a reduced nephron mass such as children
with an SK [renal agenesis (RA), multicystic dysplastic
kidney (MDK)] or after nephrectomy (Nx) (renal cancer,
kidney transplantation). These patients are especially at
risk to present a state of glomerular hyperﬁltration which
can be complicated by MA, overt proteinuria, decreased
renal function and, very rarely, renal failure, most often
secondary to FSGS [3]. The possibility of treatment of
hyperﬁltration with angiotensin-converting enzyme
inhibitors or angiotensin-receptor blockers also adds an
invaluable additional support of potential beneﬁts of our
hypothesis.
To avoid bias produced by the choice of an arbitrary
cut-off value for clearances or FF or MA, which are mul-
tiple and change with sex and age [14, 15], we explored
the association between FF and MA using continuous
values for all statistical purposes.
Materials and methods
Study sample
We prospectively studied all patients with common nephro-urological
abnormalities presenting to our unit for a complete evaluation of
their renal function. All patients with an SK (Group 1) or with bilat-
eral VUR or unilateral VUR ≥Grade II (surgically corrected or not)
(Group 2) or with severe uretero-pelvic or uretero-vesical junction
obstruction (UPJO/UVJO) (T1/2 > 20 min and/or differential distri-
bution difference >60/40%) (surgically corrected or not) (Group 3)
or other disorders such as recurrent urinary tract infections or pyelo-
nephritis (without reﬂux or obstruction), autosomal dominant poly-
cystic kidney disease or unspeciﬁed renal cystic disease, renal
trauma, horseshoe kidneys, kidneys with a history of stones, bladder
exstrophy) (Group 4) were included in the study. Patients with an
SK were further separated into three sub-groups: patients with MDK,
RA or Nx. Indications for clearance studies were left at the discre-
tion of the physician.
Blood pressure (BP) categories were deﬁned as follows: normal: BP
values <90th percentile; pre-hypertension: BP values between 90th and
95th percentile or BP values between 120 and 139/80 and 89 mmHg;
hypertension: BP values >95th percentile or BP >140/90 mmHg or pres-
ence of any anti-hypertensive treatment [16]. Body mass index (BMI)
categories were deﬁned as follows: normal: BMI <85th percentile; over-
weight: BMI between 85th and 95th percentile; obesity: BMI >95th per-
centile; underweight: BMI <5th percentile (http://www.bcm.edu/cnrc/
bodycomp/bmiz2.html). BP, weight and height were recorded to the unit,
gram and centimetre, respectively.
All groups and subgroups were deﬁned before conducting statistical
analysis. Research was conducted according to the World Medical
Association Declaration of Helsinki.
Clinical evaluation of renal function and MA
Renal function was determined in the morning, in well-hydrated subjects
given p.o. tap water or i.v. normal saline as follows: an intravenous
priming dose of 0.2 mL/kg body weight of 25% inulin and 0.02 mL/kg
body weight of 20% PAH were given, followed by a maintenance dose
of inulin and PAH in 1 mL/min of saline to provide steady-state plasma
serum levels of 300 and 20 mg/L for inulin and PAH, respectively. After
90 min of equilibration, three 30-min clearance periods provided the data
for the inulin and PAH clearances, representing GFR and renal plasma
ﬂow, respectively. Serum creatinine was measured by means of a kinetic
Jaffe method (Hitachi 917, Japan; reagents from Roche Diagnostics) and
albumin was determined by immunoturbidimetry (Roche Diagnostic).
Normal inulin clearance was deﬁned as ≥90 mL/min × 1.73m2 for both
girls and boys (range for girls >2 years of age: 105–130 mL/
min × 1.73m2, range for boys >2 years of age: 110–150 mL/
min × 1.73m2), normal PAH clearance ≥500 mL/min × 1.73m2 (range for
girls >2 years of age: 490–700 mL/min × 1.73m2, range for boys >2
years of age: 560–830 mL/min × 1.73m2) and normal FF ≤26% (range
for girls >2 years of age: 0.17–0.23, extremes 0.14–0.26; range for boys
>2 years of age: 0.17–0.21, extremes 0.14–0.26) (reference values in our
laboratory, corresponding the mean ± 2 SD in children >2 years old with
a creatinine clearance between 100 and 140 mL/min/1.73 m2).
Results for MA are reported as urinary albumin–creatinine ratio
(ACR) (mg/mmol) and urinary albumin concentration (Alb) (mg/L),
measured on a second voided morning urine specimen, during the inulin
clearance.
Renal length was determined by a renal ultrasound performed at the
same time as the clearance. Compensatory hypertrophy was deﬁned as a
kidney length >95th percentile for side and body length.
Statistical analysis
Statistical analyses were performed using STATA Microsoft tools
(STATA 10) and S-PLUS® 8.0 (Insightful Corp, Seattle, WA, USA).
Urinary Alb, urinary ACR, FF, inulin, PAH and creatinine clearances
data were included in the statistical analysis as continuous values. Basal
demographic data between groups were analysed using unpaired
Student’s t-test. Results are expressed as means ± SD, medians and
ranges or percentages. Assessment of normality of data was performed
using the Kolmogorov–Smirnov test, and data were log transformed
when applicable.
Correlation between FF and MA was assessed using the Spearman’s
rank-order correlation test. The inﬂuence of age, creatinine clearance,
urinary Alb or ACR on the FF was studied using a multivariate model.
Median FF, urinary Alb or ACR were compared between normotensive
and hypertensive patients, and also between underweight, normal- and
overweight patients. Signiﬁcance was deﬁned as P≤ 0.05.
Results
Demographics
A total of 155 subjects were prospectively enrolled to our
study. Their demographic data are shown in Table 1.
Group 1 comprised of all patients with an SK (n = 42),
Group 2 patients with VUR (n = 61), Group 3 patients
with uretero-pelvic junction obstruction/uretero-vesical
junction obstruction (UPJO/UVJO) (n = 23) and Group 4
patients with other urological diseases (n = 29). Patients
with an SK were further classiﬁed according to the
primary diagnosis, i.e. RA (n = 15), MDK (n = 19) or Nx
(n = 8). Co-morbidities in patients with an SK are listed in
Table 2. Mean age ± SD at the time of the study was
11.3 ± 5.0 years, and did not differ between groups
(P = 0.83). There was a male preponderance in every
group, except in Group 4. BP and BW characteristics are
reported in Table 1. Patients under angiotensin-converting
enzyme inhibitors and/or angiotensin-receptor blockers
were excluded.
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Determinants of MA and association between MA and FF
The values (median and range) for urinary Alb excretion,
inulin and PAH clearances and FF are reported in Table 1.
The median of inulin and PAH clearances, FF and
albumin excretion were not different between the groups
except for a signiﬁcantly diminished median PAH clear-
ance in the SK group (P < 0.001).
The association between MA and FF was studied using
the Spearman’s correlation coefﬁcients. There was a weak
but signiﬁcant correlation between urinary Alb and FF
(r = 0.32) or ACR and FF (r = 0.19) but this is only in the
SK group (Table 3).
There were no signiﬁcant differences in medians of
urinary Alb, ACR and FF between subjects with normal
and abnormal BP or between subjects with normal or ab-
normal BW (data not shown).
In a multivariate model (Table 4), the urinary Alb
(r2= 0.17, P = 0.01) or ACR (r2 = 0.13, P = 0.02) was sig-
niﬁcantly associated with FF in the SK group only. Signiﬁ-
cant association between MA and FF was lost in patients
with an SK and a GFR <90 mL/min/1.73 m2, but main-
tained in the SK group with GFR >90 mL/min/1.73 m2
(Table 5). Using the same prediction model, urinary Alb
and ACR were still signiﬁcantly associated with FF in the
subgroup of congenital SK (Table 6). Age was not associ-
ated with FF in the SK group (Table 4), whereas it was in
the VUR group (0.42, P = 0.001) and in the UPJO/UVJO
group (0.46, P = 0.04). Figure 1 shows the correlation
between MA and FF in the four groups. Given the poor
association between MA and FF in the SK group, we chose
not to calculate cut-off values using ROC curve analysis.
The absence of contralateral kidney hypertrophy
(deﬁned as a total kidney length <95th percentile accord-
ing to patient’s height and kidney side) in patients with an
SK is a very strong indicator (P < 0.001, exact Fisher test)
of low GFR (inulin clearance <90 mL/min/1.73 m2). But
there is no signiﬁcant association between the presence or
absence of contralateral kidney hypertrophy and the pres-
ence of MA.
Discussion
We prospectively studied 155 patients with concomitant
measurement of their renal function and albumin
excretion. We found a male preponderance in all our
groups with malformation (VUR, UPJO/UVJO, MDK),
except in Group 4 (children with recurrent urinary tract
infection, Table 1), which is already reported in the litera-
ture [17, 18].
Our hypothesis was that a decreased nephron mass
would lead to ﬁrst hyperﬁltration and then progressively
Table 1. Demographics and main ﬁndings
SK VUR UPJO/UVJO Othersa Total
Sample size, n 42 61 23 29 155
Age (years), median [min–max] 13 [4;21] 10 [4;24] 11 [5;22] 12 [3;21] 11 [3;24]
Sex ratio (M/F) 1.63 1.35 1.88 0.71 1.31
Albumin (mg/L), median [min–max] 6.5 [2.0;1497.0] 8.0 [1.7;412] 9.0 [3.0;75.0] 14.0 [3.0;208] 9.0 [1.7;1497]
ACR (mg/mol creatinine), median [min–max] 0.8 [0.3;120.0] 1.1 [0.4;26.6] 0.9 [0.3;10.4] 1.9 [0.5;26.4] 1.1 [0.3;120.0]
FF%, median [min–max] 24 [16;45] 23 [10;37] 23 [15;31] 22 [17;36] 24 [10;45]
PAH, median [min–max] 360 [126;682] 427 [258;1135] 425 [229;719] 429 [230;617] 406 [126;1135]
Inulin clearance, median [min–max] 93 [21;191] 96 [53;136] 103 [71;145] 99 [49;138] 97 [21;191]
Hypertension (percentile >90), n (%) 7/42 (16.7%) 6/59 (10.2%) 5/23 (21.7%) 5/29 (17.2%) 23/153 (15.0%)
Obesity, n (%)
Underweight 5/42 (11.9%) 5/61 (8.2%) 2/23 (8.7%) 1/29 (3.4%) 13/155 (8.4%)
Normal 31/42 (73.8%) 41/61 (67.2%) 19/23 (82.6%) 19/29 (65.5%) 110/155 (71.0%)
Overweight/obesity 6/42 (14.3%) 15/61 (24.6%) 2/23 (8.7%) 9/29 (31.0%) 32/155 (20.6%)
aOthers include: recurrent urinary tract infections or pyelonephritis (without reﬂux or obstruction), autosomal dominant polycystic kidney disease or
unspeciﬁed renal cystic disease, renal trauma, horseshoe kidneys, urolithiasis, bladder extrophy.
ACR, albumin–creatinine ratio; F, female; FF, ﬁltration fraction; M, male; PAH, para-aminohippurate; SK, single kidney; UPJO/UVJO, uretero-pelvic
junction obstruction/uretero-vesical junction obstruction; VUR, vesico-ureteral reﬂux.
Table 2. Associated urological anomalies or medical complications in
children with a single kidney
RA,
n = 15
MDK,
n = 19
Nx,
n = 8
VUR 3 – 2
UPJO/UVJO – 1 2
History of PN – 1 –
Increased echogenicity/
dysplasia
3 2 –
Chemotherapy – – 1
Total 6 (40%) 4 (21%) 5 (63%)
MDK, multicystic dysplastic kidney; Nx, nephrectomy; PN,
pyelonephritis; RA, renal agenesis; UPJO/UVJO, uretero-pelvic junction
obstruction/uretero-vesical junction obstruction; VUR, vesico-ureteral
reﬂux.
Table 3. Correlation with FF (Spearman correlation coefﬁcients)
SK VUR UPJO/UVJO Others
Albumin, logarithm 0.32 0.05 0.04 0.19
ACR, logarithm 0.19 −0.11 −0.23 0.08
Creatinine 0.12 0.13 0.02 0.00
Alb, urinary albumin concentration; ACR, urinary albumin/creatinine
ratio; FF, ﬁltration fraction.
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to MA, macroalbuminuria and proteinuria, secondary to
haemodynamically mediated glomerular injury [3].
This association between hyperﬁltration and MA and
this pattern of progression have already been described,
mainly in subjects with DM (although with conﬂicting
results) [6, 9–13] or hypertension [5].
We found that MA is associated with FF only in sub-
jects with an SK, but this association is very poor. Fur-
thermore, in that group, this holds true only for subjects
with a normal GFR, i.e. ≥90 mL/min/1.73 m2, but not in
subjects with an SK and lower GFRs. MA is not associ-
ated with FF in subjects with VUR, UPJO/UVJO or other
renal diseases.
The association between high FF and MA in patients
with an SK has rarely been studied according to the litera-
ture, with the notable exception of long-term evaluation
of donor kidney patients. We found three studies in which
the investigators performed inulin and PAH clearance in
patients with an SK. Regazzoni et al. found no increased
FF in adults after childhood nephrectomy [19]. Unfortu-
nately, the presence of MA was not reported. Chevallier
et al. studied children after unilateral nephrectomy for
Wilms tumour [20]. Although some children (14 of 33
children) presented a high FF, the authors found no corre-
lation between MA and hyperﬁltration, after a mean
follow-up of 4.6 years. Bock et al. [21] found only three
patients (out of 27) with MA in adult kidney donors,
again with no correlation to hyperﬁltration. In that study,
the follow-up was restricted to 1 year post nephrectomy.
Other studies relied on an abnormally high inulin or crea-
tinine clearance (often ≥2 SD) for an SK to diagnose hy-
perﬁltration, without performing PAH clearance. Baudoin
et al. found an inverse correlation between MA excretion
and GFR [22] in adult patients. Nieto et al. [23] studied
38 children after nephrectomy and found no patient with
an abnormal MA, even in the presence of hyperﬁltration
(deﬁned by an abnormally high creatinine clearance).
Morales et al. [24] found no relationship between MA
and hyperﬁltration in 85 subjects after nephrectomy.
Christensen et al. conducted a similar study and also
found MA in only one of their adult patients [25]. In
these aforementioned studies, the occurrence of MA
seems to be rather low, and without any relation to a hy-
perﬁltration state. Other studies found conﬂicting results
as to the presence [26–30] or not [31] of MA in the long-
term follow-up of patients with an SK, with no reference
to hyperﬁltration.
Recently, Abou Jaoudé et al. reported [32] a cohort of
97 children with (congenital or acquired) SK. Seventeen
per cent had MA. Because FF was not measured, an
association between a hyperﬁltration state and the pres-
ence of MAwas not available.
The fact that we found a high prevalence of MA in our
patients with an SK might be well explained by the fact
that 15 out of 42 children with an SK had moderate to
severe abnormalities in their solitary kidney (VUR or
mild hyperechogenicity or a history of recurrent pyelone-
phritis), probably lowering further their renal mass and
their renal function (Table 2). This strongly emphasizes
the fact that any secondary aggression to an SK
Table 4. Multivariate model
SK VUR UPJO/UVJO Others
Age (per year) * 0.42 (0.12), P = 0.001 0.46 (0.21), P = 0.04 ***
Creatinine 0.04 (0.03), P = 0.17 0.00 (0.01), P = 0.73 −0.02 (0.04), P = 0.55 0.02 (0.04), P = 0.64
Albumin, logarithm 1.15 (0.45), P = 0.01 −0.43 (0.51), P = 0.40 −0.06 (0.94), P = 0.95 0.54 (0.69), P = 0.44
R-squared 0.17 0.18 0.20 0.03
Age (per year) ** 0.39 (0.11), P = 0.001 0.42 (0.21), P = 0.053 ****
ACR, logarithm 1.17 (0.48), P = 0.02 −0.53 (0.60), P = 0.38 −0.36 (0.97), P = 0.71 0.29 (0.78), P = 0.71
R2 0.13 0.18 0.19 0.01
All SK subjects are included (n = 42).
Alb, urinary albumin concentration; ACR, urinary albumin/creatinine ratio; FF, ﬁltration fraction.
*Not signiﬁcant (P = 0.75), removed from the model.
**Not signiﬁcant (P = 0.85), removed from the model.
***Not signiﬁcant (P = 0.70), removed from the model.
****Not signiﬁcant (P = 0.79), removed from the model.
Table 5. Prediction model in subjects with an SK according to the GFR
level
SK/inulin GFR <90
mL/min/1.73 m2
SK/inulin GFR >90
mL/min/1.73 m2
Creatinine clearance 0.10 (0.04), P = 0.03 −0.01 (0.05), P = 0.79
Albumin, logarithm −0.36 (0.60), P = 0.56 2.09 (0.54), P = 0.001
R2 0.27 0.44
ACR, logarithm −0.12 (0.74), P = 0.87 2.18 (0.57), P < 0.001
R2 <0.01 0.41
All SK subjects are included (n = 42).
ACR, urinary albumin/creatinine ratio; GFR, glomerular ﬁltration rate;
SK, single kidney.
Table 6. Prediction model in subjects with congenital SK
Congenital SK
Albumin, logarithm 1.29 (0.46), P = 0.081
ACR, logarithm 1.50 (0.47), P = 0.034
Only subjects with congenital SK are included (n = 34).
ACR, urinary albumin/creatinine ratio; SK, single kidney.
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(hypertension, DM, obesity, chemotherapy, pyelonephri-
tis) will contribute to the development or acceleration of
MA, independently of the initial insult.
The prevalence of MA in patients with VUR has rarely
been studied. Most of the studies found an inverse corre-
lation between MA and decreased GFR and/or between
MA and the number of scars [33–36]. Interestingly, MA
was not related to hyperﬁltration in two studies [33, 35].
In one study [34], MA did not increase after an oral
protein load, leading the authors to conclude that patients
who had bilateral VUR showed an impaired renal
response to protein load, with no renal functional reserve
capacity. Although our patients with VUR had MA, we
found no signiﬁcant association between MA and FF in
that group. It seems that renal scars by themselves (in the
case of VUR), independently or in addition to haemo-
dynamic factors, could induce MA in children with VUR.
The occurrence of hyperﬁltration in these patients will
nevertheless play an additional role in the appearance of
MA, and should be managed as such.
In summary, we found a weak association between FF
and MA, and only in subjects with an SK and GFRs >90
mL/min/1.73 m2. In all other groups, MA is not associ-
ated with FF. MA cannot be used to predict hyperﬁltration
in children with common nephro-urological disorders.
This leads to two ﬁnal remarks: there must be other bio-
markers, yet unidentiﬁed, that could better predict hyperﬁl-
tration. MA in children with nephro-urological disorders
must also be secondary to other factors than a high FF.
Most of the ﬁltered albumin is reabsorbed at the proximal
tubule level [37]. Pathological MA could also be present
secondary to cellular proximal tubular dysfunction [38].
We are aware of a few limitations in our study. The
method most commonly used to measure MA relies on a
timed urine collection, either a 24-h or overnight speci-
men, which is time-consuming and often inaccurate in
children. MA has been measured only once in our study,
during the clearance studies, in the second morning urine
specimen. Several studies have shown an excellent corre-
lation between the MA excretion measured in 24-h urine
collections and the random urine ACR [39]. The beneﬁt
of MA treatment in children with an SK remains to be
proven as well with long-term outcome studies. Further-
more, our population with an SK had a very high inci-
dence of associated and potentially deleterious conditions
such as pyelonephritis, cancer, reﬂux, obstruction. This
might have increased the prevalence of MA in such a se-
lected population, and therefore the strength of association
between MA and FF. The results we found might not
apply in a more general population. Hence, additional
studies should be conducted in a more representative
population, and in children with isolated SK and no other
anomalies/conditions.
Conclusion
Hyperﬁltration is not associated with MA in subjects
with chronic kidney disorders, except in children with
an SK and normal GFR. However, the association
between FF and MA in that subgroup is very weak.
MA cannot be used as a surrogate marker for hyperﬁl-
tration. Other unidentiﬁed factors must play a role in the
development of MA in patients with nephro-urological
disorders.
Conﬂict of interest statement. None declared.
Fig. 1. ACR, albumin–creatinine ratio. Red dots denote inulin GFR <90 mL/min/1.73 m2, blue dots inulin GFR ≥90 mL/min/1.73 m2. There is a
weak association between ACR and FF only in subjects with a SK.
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